← Leaderboards
Ann Morgan Cathcart
Dana-Farber Cancer Inst
$71,924
Attributed
$71,924
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.2K · FY2017–18$50K$37.5K$25K$12.5K$0
'17
'18
Funding mix
By agency
NIH$71,924 · 1
By mechanism
F30$71,924 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Piotr Sicinski$42,703,610
- Jeffrey Wade Harper$36,219,392
- Bruce M Spiegelman$59,708,812
- Nathanael Schiander Gray$36,761,550
- Donald W. Kufe$50,160,456
Others in their field
Other Emerging Leaders on “Alanine”
- Gary Fanger · Rise Therapeutics, Llc$5,581,127
- Jacquelyn Gorman · Oklahoma Medical Research Foundation$4,662,779
- Jinhong Chang · Baruch S. Blumberg Institute$3,536,341
- Ben Doranz · Integral Molecular$3,028,905
- Maliha Zahid · Vivasc Therapeutics Inc.$2,981,992
- Andrew David Schreiner · Medical University Of South Carolina$2,682,628
Research focus
AlanineAlpha HelixApoptosisApoptoticBindingBiotinCancer BiologyCancer CellCancer Cell LineCareerCell Cycle ArrestCell DeathCell LineCellsChemical SynthesisChemistryChemotherapeutic AgentClinical OncologyComplementComplexCrispr/Cas TechnologyCrystallizationDana-Farber Cancer InstituteAcute Myelocytic Leukemia